Last edition
News about "MINDFuL trial"
INmune Bio Publishes Phase 2 MINDFuL Trial Results, Advances XPro Platform in Dementia
INmune Bio published phase 2 MINDFuL trial results in NPJ Dementia, highlighting XPro’s safety, biomarker engagement, and clinical efficacy in patients with mild Alzheimer’s Disease (AD).
MINDFuL Trial | 18/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members